Literature DB >> 15099655

Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program.

Michael Kidorf1, Elizabeth R Disney, Van L King, Karin Neufeld, Peter L Beilenson, Robert K Brooner.   

Abstract

The present study evaluates the prevalence of psychiatric and substance use disorders in male and female intravenous opioid abusers participating at a community needle exchange program (NEP). All participants (n = 422) were administered the Structured Clinical Interview for the DSM-IV (SCID) for Axis I disorders and antisocial personality disorder (APD). Psychiatric and substance abuse comorbidity were highly prevalent. Major depression was the most common current and lifetime Axis I non-substance use disorder (6 and 21% of the sample, respectively); 37% were diagnosed with APD. Over 50% of the sample was diagnosed with at least one non-substance use Axis I disorder or APD. In addition to opioid dependence, cocaine dependence was the most prevalent current and lifetime substance use disorder (68 and 78% of the sample, respectively), followed by alcohol and cannabis dependence. Overall, participants reported a mean of over one current and over three lifetime substance use disorders in addition to opioid dependence. Women reported higher rates of post-traumatic stress disorder (PTSD), while men were more likely diagnosed with APD. Presence of a psychiatric disorder was associated with increased prevalence of substance use disorder for all drug classes. The high rates of comorbidity observed in this sample suggest that the harm reduction efforts of NEPs can be significantly enhanced through referral of participants to programs that treat substance use and/or other psychiatric disorders.

Entities:  

Mesh:

Year:  2004        PMID: 15099655     DOI: 10.1016/j.drugalcdep.2003.11.014

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  57 in total

Review 1.  Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

Authors:  Colin N Haile; James J Mahoney; Thomas F Newton; Richard De La Garza
Journal:  Pharmacol Ther       Date:  2012-01-31       Impact factor: 12.310

2.  Use of Medicaid data to explore community characteristics associated with HIV prevalence among beneficiaries with schizophrenia.

Authors:  James Walkup; Ayse Akincigil; Donald R Hoover; Michele J Siegel; Shahla Amin; Stephen Crystal
Journal:  Public Health Rep       Date:  2011 Sep-Oct       Impact factor: 2.792

3.  A treatment reengagement intervention for syringe exchangers.

Authors:  Michael Kidorf; Van L King; Jessica Peirce; Ken Kolodner; Robert K Brooner
Journal:  J Subst Abuse Treat       Date:  2011-08-09

4.  Reliability and validity of the Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) in patients with drug and alcohol use disorders.

Authors:  Shannon Byrne; Nancy M Petry
Journal:  AIDS Care       Date:  2012-05-30

5.  Prevalence of mood and substance use disorders among patients seeking primary care office-based buprenorphine/naloxone treatment.

Authors:  Jonathan D Savant; Declan T Barry; Christopher J Cutter; Michelle T Joy; An Dinh; Richard S Schottenfeld; David A Fiellin
Journal:  Drug Alcohol Depend       Date:  2012-07-06       Impact factor: 4.492

6.  Perceived mental health status of drug users with HIV: concordance between caregivers and care recipient reports and associations with caregiving burden and reciprocity.

Authors:  Mary M Mitchell; Allysha C Robinson; Jennifer L Wolff; Amy R Knowlton
Journal:  AIDS Behav       Date:  2014-06

7.  Psychiatric and substance use disorders among methadone maintenance patients with chronic hepatitis C infection: effects on eligibility for hepatitis C treatment.

Authors:  Steven L Batki; Kelly M Canfield; Robert Ploutz-Snyder
Journal:  Am J Addict       Date:  2011-05-31

8.  Psychiatric Disorders Among Patients Seeking Treatment for Co-Occurring Chronic Pain and Opioid Use Disorder.

Authors:  Declan T Barry; Christopher J Cutter; Mark Beitel; Robert D Kerns; Christopher Liong; Richard S Schottenfeld
Journal:  J Clin Psychiatry       Date:  2016-10       Impact factor: 4.384

9.  Low prefrontal perfusion linked to depression symptoms in methadone-maintained opiate-dependent patients.

Authors:  Jesse J Suh; Daniel D Langleben; Ronald N Ehrman; Jonathan G Hakun; Ze Wang; Yin Li; Samantha I Busch; Charles P O'Brien; Anna Rose Childress
Journal:  Drug Alcohol Depend       Date:  2008-07-31       Impact factor: 4.492

10.  Psychiatric distress, risk behavior, and treatment enrollment among syringe exchange participants.

Authors:  Michael Kidorf; Van L King; Jessica Peirce; Christopher Burke; Ken Kolodner; Robert K Brooner
Journal:  Addict Behav       Date:  2010-01-04       Impact factor: 3.913

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.